Hi everyone in this bonus episode of the evidence-based birth podcast we're going to talk about the results of the arrive study.

Welcome to the evidence Space Birth Podcast.

Join us each week as I tackle the evidence on another hot topic about childbirth.

As a reminder, this information is not medical advice.

See EB Birth.com slash disclaimer for more details.

Hi everyone, my name is Rebecca Decker. I'm a nurse with my PhD and the founder of

Evidence-based Birth so I'm sure a lot of you heard the big news about the

arrive study being presented at the conference for the Society for Maternal Fetal Medicine.

The Arrives study is called a randomized trial of induction versus expectant management.

And it was funded by the Eunice Kennedy Shriver National Institute

of Child Health and Human Development and conducted by the N. I. C.H.D. maternal fetal medicine

units. They wanted to look at the effects of

elective induction at 39 weeks and their primary purpose of doing the study was to

look at the effects of this practice on a combined measure of newborn death and illness.

A secondary reason was they wanted to look at the effects on the caesarian rate.

So many people all over the United States were inducing moms at 39 weeks. It was becoming so common that they wanted to do a

randomized trial to find out the effects. There have been some smaller randomized

trials on this topic with mixed findings and now arrive was the largest

study of its kind. The arrive study took place at 16 different hospitals across

the United States. There were hospitals in Alabama, California, Colorado, Illinois, New York,

North Carolina, Ohio, Pennsylvania, Rhode Island, Texas, and Utah. Most of these were

university hospitals. You can only be eligible to be in

...